BEIJING (AP) _ Sinovac Biotech Ltd. (SVA) on Friday reported a second-quarter loss of $3.8 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Beijing-based company said it had a loss of 5 cents. Losses, adjusted for stock option expense and non-recurring costs, came to 4 cents per share.
The biopharmaceutical company posted revenue of $52.3 million in the period.
Sinovac shares have decreased nearly 7% since the beginning of the year. In the final minutes of trading on Friday, shares hit $6.47, a decline of 21% in the last 12 months.